Kanada - angleščina - Health Canada

omega laboratories limited - haloperidol - solution - 5mg - haloperidol 5mg - butyrophenones

Združene države Amerike - angleščina - NLM (National Library of Medicine)

cardinal health - haloperidol lactate (unii: 6387s86pk3) (haloperidol - unii:j6292f8l3d) - haloperidol 5 mg in 1 ml

Združene države Amerike - angleščina - NLM (National Library of Medicine)

clinical solutions wholesale - haloperidol (unii: j6292f8l3d) (haloperidol - unii:j6292f8l3d) - haloperidol 0.5 mg

Združene države Amerike - angleščina - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - haloperidol (unii: j6292f8l3d) (haloperidol - unii:j6292f8l3d) - haloperidol 1 mg

Združene države Amerike - angleščina - NLM (National Library of Medicine)

remedyrepack inc. - haloperidol (unii: j6292f8l3d) (haloperidol - unii:j6292f8l3d) - haloperidol 1 mg

Združene države Amerike - angleščina - NLM (National Library of Medicine)

mckesson contract packaging - haloperidol (unii: j6292f8l3d) (haloperidol - unii:j6292f8l3d) - haloperidol 5 mg

Združene države Amerike - angleščina - NLM (National Library of Medicine)

cardinal health - haloperidol (unii: j6292f8l3d) (haloperidol - unii:j6292f8l3d) - haloperidol 5 mg in 1 ml

Združene države Amerike - angleščina - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - haloperidol lactate (unii: 6387s86pk3) (haloperidol - unii:j6292f8l3d) - haloperidol 5 mg in 1 ml

Združene države Amerike - angleščina - NLM (National Library of Medicine)

clinical solutions wholesale, llc - haloperidol (unii: j6292f8l3d) (haloperidol - unii:j6292f8l3d) - haloperidol 5 mg

Združene države Amerike - angleščina - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - haloperidol (unii: j6292f8l3d) (haloperidol - unii:j6292f8l3d) - haloperidol is indicated for use in the management of manifestations of psychotic disorders. haloperidol is indicated for the control of tics and vocal utterances of tourette’s disorder in children and adults. haloperidol is effective for the treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted for by immediate provocation). haloperidol is also effective in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance. haloperidol should be reserved for these two groups of children only after failure to respond to psychotherapy or medications other than antipsychotics. haloperidol is contraindicated in severe toxic central nervous system depression or comatose states from any cause and in individuals who are hypersensitive to this d